Literature DB >> 27614229

The JAK2 V617F mutation and thrombocytopenia.

Stephen E Langabeer1, Karl Haslam2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27614229     DOI： 10.1016/j.hemonc.2016.08.006

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


× No keyword cloud information.
  2 in total

1.  Molecular analysis of V617F mutation in Janus kinase 2 gene of breast cancer patients.

Authors:  Sajjad Karim; Imran Riaz Malik; Quratulain Nazeer; Ahmad Zaheer; Muhammad Farooq; Nasir Mahmood; Arif Malik; Muhammad Asif; Asim Mehmood; Abdul Rehman Khan; Abdul Jabbar; Muhammad Arshad; Qudsia Yousafi; Abrar Hussain; Zeenat Mirza; Muhammad Atif Iqbal; Mahmood Rasool
Journal:  Saudi J Biol Sci       Date:  2019-08-02       Impact factor: 4.219

2.  Treatment outcome of Philadelphia chromosome negative myeloproliferative neoplasms: experience of a single developing country's hematology-oncology centre.

Authors:  Mohammed Salim; Zrari Salar
Journal:  Afr Health Sci       Date:  2019-09       Impact factor: 0.927
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.